List view / Grid view
17 December 2015 | By Victoria White
The Scientific Advisory Board comprises nine leading academics and industry executives with a world-class breadth of expertise across the Company’s areas of operation...
17 December 2015 | By Victoria White
The new premises will accommodate the Company’s US clinical development, medical and regulatory operations and provide an important base for Immunocore’s ongoing US activities...
15 December 2015 | By Victoria White
There are thought to be as many as 600,000 protein-protein interactions that could be targets for new drugs. The project seeks to analyse and categorise the important features of these interactions...
15 December 2015 | By Victoria White
Researchers have shown that the presence or absence of the CAP2 gene causes sudden cardiac death in mice...
15 December 2015 | By Victoria White
The "Takeda-CiRA Joint Programme for iPS Cell Applications" (T-CiRA) will begin research in six core directions to explore clinical applications of stem cells in therapeutic areas including cancer, heart failure and diabetes mellitus...
15 December 2015 | By Victoria White
The new facility will support science- and technology-based companies striving to build businesses that originated with research from universities and increase their impact...
15 December 2015 | By Victoria White
A new study, conducted by researchers at the Karolinska Institutet and Gothenburg University, describes a possible mechanism for how the gene variant produces clinical symptoms by affecting levels of specific proteins in the brain...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
14 December 2015 | By Victoria White
Their research identified eight complete strains of human pegivirus 2, which makes it the first study to reveal the entire genetic makeup of this new virus...
14 December 2015 | By Victoria White
Bristol-Myers Squibb and the David Geffen School of Medicine at UCLA will conduct a range of early phase clinical studies as part of the I-O RPM research programme...
14 December 2015 | By Victoria White
Bellicum has been granted rights to develop and commercialise adoptive cell therapies for tumours expressing Prostate Stem Cell Antigen (PSCA) using PCSA technology in-licensed and developed at Agensys...
11 December 2015 | By Victoria White
A new study shows how different pharmaceutical drugs hit either the "on" or "off" switch of β2AR - signalling protein linked to asthma, obesity and type 2 diabetes...
11 December 2015 | By Victoria White
The study will look at the safety and tolerability of PnuBioVax for three different dosages against the bacterial pathogen Streptococcus pneumoniae...
11 December 2015 | By Victoria White
The companies have joined WCPR to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome...
10 December 2015 | By Victoria White
SRI Biosciences and physician-researchers from Stanford Cancer Institute (SCI) are to pursue development of novel compounds to treat multiple forms of cancer and other conditions...
